KHOO TECK PUAT HOSPITAL
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- -
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study
- First Posted Date
- 2014-07-28
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Khoo Teck Puat Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02201602
- Locations
- 🇸🇬
Khoo Teck Puat Hospital, Singapore, Singapore
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
Phase 4
Completed
- Conditions
- Type II Diabetes in Subjects BMI 27 to 32
- Interventions
- Procedure: Roux-en-Y Gastric Bypass (RYGB)Drug: Incretin analoguesDrug: SGLT2 inhibitorsDrug: DPP-4 Inhibitors
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Khoo Teck Puat Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02041234
- Locations
- 🇸🇬
Khoo Teck Puat Hospital, Singapore, Singapore
Effects of Resveratrol in Patients With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2012-09-03
- Last Posted Date
- 2012-09-03
- Lead Sponsor
- Khoo Teck Puat Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01677611
- Locations
- 🇸🇬
Alexandra Health, Khoo Teck Puat Hospital, Singapore, Singapore
© Copyright 2025. All Rights Reserved by MedPath